Certolizumab Pegol for Plaque Psoriasis: 2-Year Efficacy Results from 2 Phase 3 Trials (CIMPASI-1 and CIMPASI-2)
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
10-2019
Journal Title
Journal of the American Academy of Dermatology
Department
Dermatology
Recommended Citation
Gordon, K., Reich, K., Blauvelt, A., Thaci, D., Leonardi, C., Poulin, Y., Boehnlein, M., Kavanagh, S., Arendt, C., & Gottlieb, A. B. (2019). Certolizumab Pegol for Plaque Psoriasis: 2-Year Efficacy Results from 2 Phase 3 Trials (CIMPASI-1 and CIMPASI-2). Journal of the American Academy of Dermatology, 81 (4 Suppl. 1), AB195. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/282
COinS
